US Non-Invasive Prenatal Diagnostics - Market Insight

1
US Non-Invasive Prenatal Diagnostics - Market
Insight

• Bharat Book Bureauwww.bharatbook.com

2
Summary

• The US prenatal diagnostics market is one of
  the largest markets in the world for fetal
  monitoring, diagnostics, and predictive testing.
  It consists of a series of physician prescribed
  tests for monitoring maternal and fetal health.
  The current invasive technologies such as CVS and
  amniocentesis that are used to detect chromosomal
  abnormalities pose serious risks of miscarriages
  and are being replaced by the non-invasive
  prenatal diagnostic technologies.
• Although NIPD is a relatively nascent segment
  of the prenatal diagnostics, it presents a
  lucrative growth potential to industry
  participants. The segment is mainly supported by
  rising incidences of fetal health-related
  abnormalities and the urgent need for safe,
  accurate and early diagnosis. Products such as
  MaterniT21 Plus, Verifi, and Harmony prenatal
  tests are the current tests available in the
  market.

3
Table of Contents

• 1. Analyst View 2. Research Methodology 3.
  Statistical Snapshot - Pregnancies and
  Chromosomal Abnormalities 4. Overview of US
  Prenatal Diagnostics Market 4.1
  Introduction 4.2 Prenatal Diagnostics
  Industry 4.2.1 Preliminary Prenatal
  Testing 4.2.2 First Trimester Screening 4.2.3
  Second Trimester Screening 4.2.4 Chorionic
  Villus Sampling (CVS) Testing 4.2.5
  Amniocentesis Testing 5. US Non-Invasive
  Prenatal Diagnostics - Market Insight 5.1 Tests
  Available in the Market 5.1.1 MaterniT21
  (Sequenom) 5.1.2 Verifi (Verinata) 5.1.3
  Harmony Prenatal Test (Ariosa Diagnostics)

4
For more information

• Kindly click on
• http//www.bharatbook.com/market-research-repo
  rts/healthcare-market-research-report/us-non-invas
  ive-prenatal-diagnostics-market-insight.html 
  
• Or visit

Bharat Book Bureau Phone [phone],
27810773 Fax [phone] E-mail
info_at_bharatbook.com Website www.bharatbook.com